ABSTRACT Inactivation of excitation-contraction coupling was examined in extensor digitorum longus (EDL) and soleus muscle fibers from rats injected daily with tri-iodothyronine (T3, 150 t~g/kg) for 10-14 d. Steady-state activation and inactivation curves for contraction were obtained from measurements of peak potassium contracture tension at different surface membrane potentials. The experiments tested the hypothesis that noninactivating tension is a "window" tension caused by the overlap of the activation and inactivation curves. Changes in the amplitude and voltage dependence of noninactivating tension should be predicted by the changes in the activation and inactivation curves, if noninactivating tension arises from their overlap. After T3 treatment, the area of overlap increased in EDL fibers and decreased in soleus fibers and the overlap region was shifted to more negative potentials in both muscles. Noninactivating tension also appeared at more negative membrane potentials after T3 treatment in both EDL and soleus fibers. The effects of T3 treatment were confirmed with a two microelectrode voltage-clamp technique: at the resting membrane potential (-80 mV) contraction in response to a brief test pulse required less than normal depolarization in EDL, but more than normal depolarization in soleus fibers. After T3 treatment, the increase in contraction threshold at depolarized holding potentials (attributed to inactivation) occurred at more depolarized holding potentials in EDL, or less depolarized holding potentials in soleus. The changes in contraction threshold could be accounted for by the effects of T3 on the activation and inactivation curves. In conclusion, (a) T3 appeared to affect the expression of both activation and inactivation characteristics, but the activation effects could not be cleanly distinguished from T3 effects on the sarcoplasmic reticulum and contractile proteins, and (b) the experiments provided evidence for the hypothesis that the noninactivating tension is a steady-state "window" tension.
INTRODUCTION
Inactivation of excitation-contraction coupling in skeletal muscle fibers causes the spontaneous decay of contracture tension developed during prolonged depolariza-tion. The decay of tension is often incomplete and a noninactivating component of tension has been described (Chua and Dulhunty, 1988) . It was suggested (Chua and Dulhunty, 1988 ) that noninactivating tension is analogous to "window" sodium currents in cardiac muscle (Attwell et al., 1979; Colatsky, 1982) and that it is a steadystate tension arising from the overlap of the tension activation and inactivation curves. It was further suggested that the overlap of the tension-activation and inactivation curves influences the contraction threshold measured with a brief test pulse during prolonged depolarization under voltage-clamp conditions. Both suggestions were tested in the present experiments in which the voltage dependence of the activation and inactivation curves were altered by chronic administration of tri-iodothyronine (T3).
The voltage sensitivity of contractile activation is altered in rat EDL and soleus muscles after T3 treatment (Dulhunty et al., 1987) and preliminary experiments suggest that the voltage sensitivity of inactivation is also affected (Chua and Dulhunty, 1985) . The results reported here confirm the effects of excess thyroid hormone on inactivation and support the hypothesis that noninactivating tension arises from the overlap of activation and inactivation curves. Further, the results suggest that changes in the voltage dependence of activation and inactivation accounts not only for the effects of T3 on noninactivating tension but also for the drug's effect on the relationship between contraction threshold and holding potential.
METHODS

Biological Preparation and Solutions
EDL and soleus muscles were removed from normal and thyrotoxic male Wistar rats (300-400 g) and dissected in a Sylgard (Dow Coming Corp., Midland, MI) -lined dish into bundles of 5-10 fibers for K contractures or layers, 2-5 fibers thick, for microelectrode studies. Rats were made thyrotoxic with dally intraperitoneal injections of TB (150 t~g/kg body weight) for 10-14 d. Administration of T3 for this period resulted in the characteristic changes in contractile properties listed in Table I : there was a reduction in the ratio of twitch to tetanic tension in EDL and soleus fibers, a reduction in the 20-80% rise time (see definition below) of twitch tension, and a reduction in the 80-20% decay time (see definition below) of the tetanus in both types of muscle. Twitch relaxation became faster than normal only after 2-3 wk of T3 treatment (unpublished observations).
The composition of Krebs, low C1, and high K solutions are given in Dulhunty and Gage (1985) . Solutions for voltage-clamp experiments contained tetrodotoxin, 2 x 10 -7 M, to eliminate action potentials. Fibers were equilibrated in a low Cl solution to avoid effects of the high C1 permeability in mammalian T tubule membranes (Dulhunty, 1979; Chua and Dulhunty, 1988) . The use of low C1 solutions also reduced the effects of changes in the [K + ] x [C1-] product during exposure to high K solutions, and the slow potential changes seen during the redistribution of chloride ions (Hodgkin and Horowicz, 1960) were small or not seen (Dulhunty, 1979) . The membrane potential changed rapidly and reached 90% of the steadystate value within 10 s of the solution change. Experiments were done at 21 _+ 1~
Isometric Tension Recording, K Contractures, and Contraction Threshold
Methods for (a) stimulating and recording isometric twitches and tetani, K contractures, and steady-state inactivation, and (b) recording membrane potentials, voltage clamp, and visualization of contraction threshold, are described in detail in Chua and Dulhunty (1988) .
Steady-state inactivation was always measured after 3 rain of depolarization either in a conditioning K solution or under two microelectrode voltage clamp. The 3-min period was chosen because good recovery of tension could usually be obtained after this short period of depolarization, the rapid phase of inactivation was complete, and subsequent changes in inactivation were relatively slow. However, the situation was not a true steady-state situation because the inactivation process in soleus muscles continues slowly for at least 10-15 min after depolarization (unpublished observations).
Definitions 20-80% rise time of twitch, tetanus, or K contracture tension is the time taken for tension to increase from 20 to 80% of peak tension.
80-20% decay time of twitch, tetanus, or K contracture tension is the time taken for tension to decay from 80 to 20% of the peak tension.
Threshold membrane potential (for contraction) is measured during voltage-clamp experiments and is the membrane potential during a brief test pulse to a potential that is 0.2 mV The results are presented as mean • 1 SEM with the number of preparations in parentheses. Results in which T3-treated fibers were significantly different (0.0001 < P < 0.001, Student's t tes0 from normal are marked with an asterisk and NS denotes no significant difference.
more negative than the potential at which contraction can just be observed (Chua and Dulhunty, 1988 ).
Contraction threshold is used interchangeably with "threshold membrane potential." Pedestal tension is the noninactivating component of tension that appears as a pedestal after the spontaneous decay of K contractures.
Excitable fibers are fibers that generate tension when exposed to a 200-raM K solution, or fibers that contract in response to a voltage-clamp test pulse to membrane potentials of +20 mV or less.
Inexcitablefibers are fibers that do not generate tension after exposure to a 200 mM K solution, or fibers that will not contract in response to a voltage-clamp test pulse to membrane potentials of +20 mV or less.
THE JOURNAL OF GENERAL PHYSIOLOGY. VOLUME Aaivation parameters refer to the slope and voltage for half-maximal tension obtained from the activation curve.
Inactivation curves are curves obtained by fitting a Boltzmann-type equation to peak K contracture tension (measured in test 200-mM K solutions) plotted against the membrane potential in a conditioning high K solution (i.e., [K] < 200 mM) added 3 min before the test K solution.
Inactivation parameters refer to the slope and voltage for half-maximal tension obtained from the inactivation curve.
RESULTS
Effects of T3 Treatment on Membrane Potential
Membrane potentials in low CI or high K solutions (Table II) were not altered after T3 treatment for 10-14 d or 8 wk. This suggested that resting membrane permeabilities were also unaltered: Ismail-Beigi and Edelman (1973) found that internal Na, K, and C1 concentrations were normal in hyperthyroid animals. Reported depolarization in thyrotoxic fibers (Hoffman and Denys, 1972; Gruener et al., 1975; McArdle et al., 1977) may be related to the fragility of the fibers (see below).
K Contractures and Pedestal Tension
K contractures were faster than normal in T3-treated fibers (Fig. 1) . On average, the 20-80% rise time of 120 mM K contractures decreased from 4.0 _+ 0.3 to 3.1 + 0.2 s in, respectively, 12 control and 27 bundles of T3-treated EDL fibers, and the 80-20% decay time fell from 15.9 + 1.2 to 10.2 + 0.4 s. In soleus, the 20-80% rise time fell from 4.5 + 0.4 to 3.5 + 0.14 s, and the decay fell from 23.2 -+ 2.5 to 10.7 + 0.6 s in, respectively, 10 control and 30 T3-treated preparations. In each case the data from T3-treated preparations was found to be significantly different from the control data at the 0.01 level using the Wilcoxon (Mann-Whitney) rank-sum test (Davore, 1982) .
Noninactivating tension is apparent after the contractures in 40 and 80 mM K shown in Fig 2. The records were chosen to show clear examples of the pedestal tension. The amount of noninactivating tension is not directly proportional to the tension generated during the K contracture and probably also depends on the amount of inactivation at each potential (see model presented below). The 80 mM K contracture in Fig. 2 C was larger than the 40 mM K contracture in Fig. 2 A, yet the pedestal tension, as a percentage of tetanic tension (see legend to Fig. 2) , is similar in both examples. Noninactivating tension was zero after 200 mM K contractures in normal and T3-treated fibers. After T3 treatment, more noninactivating tension was seen at lower K concentrations (Table III) . Consequently, in soleus, the decay of some 40 mM K contractures was insignificant because the amplitude of noninactivating tension was similar to the contracture tension (Fig. 2 D) .
At K concentrations <200 raM, the amplitude of contractures in T3-treated EDL fibers was greater than normal (Fig. 3 A) . After T3 treatment, average contracture tension in 80 and 120 mM K was significantly different from normal at the 0.01 level (Wilcoxon rank-sum test). The control data is given in Chua and Dulhunty (1988) . T3-treated soleus fibers generated significantly less (0.01 level, Wilcoxon rank-sum test) than normal tension at all K concentrations (Fig. 3 B) . Tetanic ten- sion was equivalent to maximum tension in both muscles after T3 treatment, in contrast to normal soleus fibers where maximum K contracture tension is 20% greater than maximum tetanic tension.
Effect of Thyroid Hormone on the Voltage Dependence of Activation
The curves in Fig. 3 show the best fit to the data of a Bohzmann-type equation (Dulhunty and Gage, 1983) :
Ta is K contracture amplitude at a membrane potential Vm, Tm~, is maximum tension, V, is the potential at which T, = 0.5 T~,, and k, is a slope factor. Boltzmann equations, although not strictly applicable to the tension vs. membrane potential situa- Table IV. tion, provide a basis for comparing data (Dulhunty and Gage, 1983; Chua and Dulhunty, 1988) . V= was shifted to more negative potentials (from -18 to -24 mV in T3-treated EDL fibers), but was shifted to more positive potentials (from -31 to -26.8 mV) in soleus (Table IV) . Changes in contraction threshold after T3 treatment, suggested by the activation curves in Fig. 3 , were also seen in the two microelectrode voltage-clamp experiments with long (> 100 ms) test pulses. The threshold potentials in T3-treated EDL fibers (filled symbols, Fig. 4 A) were more negative than control (P < 0.05) and the thresholds in soleus (filled symbols, Fig. 4 B) were more positive than control (P < 0.001). Significance was based on F values obtained from an analysis of variance for repeated measures, assuming a linear relationship between threshold and pulse duration for durations of 100-2,000 ms.
Surprisingly, the threshold for brief pulses decreased in both EDL and soleus fibers after T3 treatment: for 2-ms pulses there was a decrease from an average potential of -9.2 _+ 1.6 mV (n = 32) to -24.1 + 2.6 mV in 14 T3-treated EDL fibers, and from -18.5 -+ 1.1 mV (n = 26) to -32.1 + 1.7 mV in 18 T3-treated soleus fibers. The reduction in threshold in both cases was found to be significant at the 0.01 level using the Wilcoxon rank-sum test. The reduced threshold can probably be attributed to more efficient T tubule depolarization because of the lower T tubule access resistance resulting from expansion of the tubular openings onto the surface of thyrotoxic fibers in both types of muscle (Dulhunty et al., 1986) .
Effect of T3 Treatment on Steady-State Inactivation
Steady-state inactivation was assessed from the amplitude of test 200 mM K contractures after a 3-rain equilibration in conditioning solutions containing 10-160 mM K (Chua and Dulhunty, 1988) . After T3 treatment there was a less than normal depression of tension in EDL fibers and a more than normal depression in soleus (Fig. 5) 
Fictn~ 5. Steady-state inactivation measured using K contracture techniques. 200 mM K contracture tension is plotted against the membrane potential in conditioning high K solutions. The K concentrations in the conditioning solutions are given along the top of the graph opposite the corresponding membrane potentials (also listed in Table I ). The amplitude of the test 200 mM K contractures recorded after 3 nfin equilibration in the conditioning K solution is expressed relative to the mean amplitude of control 200 mM K contractures recorded before and after the test contracture, after equilibration in the control, 3.5 mM K, solution. The filled symbols show the average relative tension in EDL (A) and soleus (B) fibers from T3-treated animals. The vertical bars denote _ 1 SEM where this is greater than the dimensions of the symbol. The solid lines show the best fit by eye of Eq. 2 (see text) to the T3 data. The broken lines, taken from Chua and Dulhunty (1988) are the best fit of Eq. 2 to control data and are included for comparison. Constants used to construct the curves are listed in Table IV. equation of the form (see e.g., Rakowski, 1981) :
where Ti is the amplitude of the test contracture at a conditioning potential Vo ~ is the potential at which T~ = 0.5 T~, and ki is a slope factor. In EDL fibers k~ fell from a control value of 10 mV to 5.8 mV, and there was a positive shift in V~, from -52 to -43.5 mV (Fig. 5 , Table IV ). In contrast, in soleus fibers, there was a negative shift in ~, from -34 to -38 mV.
Similar effects of thyroid hormone were seen during the two microelectrode voltage-clamp experiments. After T3 treatment the increase in contraction threshold as a result of inactivation occurred at more positive holding potentials in EDL fibers and at more negative potentials in soleus (Fig. 6) . The fibers in Fig. 6 were typical of 17 control EDL, 6 T3-treated EDL, 14 control soleus, and 7 T3-treated soleus fibers (T3-treated fibers were fragile and susceptible to damage by microelectrodes and the number of successful experiments was small). At a holding potential of -36 mV, 50% of normal EDL fibers did not contract in response to a 15-ms test pulse whereas, after T3 treatment, a more depolarized holding potential (-25.5 mV) was necessary to reduce to 50% the number of fibers that responded to the same test pulse (Fig. 7 A) . The potential at which 50% of the fibers no longer responded to the test pulse fell from -27.5 to -42.5 mV in T3-treated soleus fibers (Fig. 7 B) . Calculations of steady-state tension (below) assume that activation and inactivation are independent processes. The opposite changes in the voltage sensitivity of inactivation (a positive shift in EDL and a negative shift in soleus) and activation (a negative shift in EDL and a positive shift in soleus) suggest that this assumption may be valid.
Prediction of Steady-State Tension
Changes in the amplitude and voltage dependence of noninactivating tension should be predicted by the changes in steady-state activation and inactivation curves in T3-treated fibers if noninactivating tension arises from overlap of the two curves. After T3 treatment the "voltage window" between the activation and inactivation curves was at more negative membrane potentials in EDL (Fig. 8 A) and soleus (Fig.  8 B) fibers. Also, the area of overlap increased in EDL, but was reduced in soleus.
Steady-state tension was calculated from the curves in Fig. 8 using two assump- 
where Vn~. ~'a, and ka have the same meanings as in Eq. 1, and tension in the activation curves (Fig. 3) , T~, is equal to a| (where Tm~ is maximum tension). Secondly, it was assumed that inactivation is described by a steady-state inactivation variable, i| defined by:
where Vr Vi, and kl have the same meanings as in Eq. 2 and tension in the inactivation curves (Fig. 5) , Ti, is equal to i| Steady-state tension, T| is therefore given by:
The curves in Fig. 8 define a| and i| since T~, was normalized to a value of 1. Therefore the constants for Va, Vi, ka, and ki (Table IV) were used to calculate a| and i| and hence T| (Fig. 9) . The amplitude of noninactivating tension measured in T3-treated fibers is also shown in Fig. 9 . The predicted curves provide a good fit to Table IV . The graphs illustrate the effect of T3 treatment on the area of overlap between the activation and inactivation parameters. the data, supporting the suggestion that the noninactivating tension is a steady-state tension.
A Three-State Model for Contractile Activation
The results were consistent with a model (Chua and Dulhunty, 1988 ) that makes the following assumptions: (a) Contraction is controlled by an activator that exists in precursor, active, or inactive forms. (b) Tension depends on activator concentrations above a constant threshold value. (c) Steady-state tension at a depolarized membrane potential (e.g., V~ in Fig. 10 ), at which r| > 0, depends on a steady-state concentration of activator, Ao<v~), which is given by:
where r| is a steady-state, voltage-dependent variable describing the concentration of precursor converted to an active form, h| is a steady-state, voltage-dependent variable describing the concentration of activator converted to an inactive form, and A~, is maximum activator concentration. (d) The tension activation and inactivation variables, a| and i| are related to r| and h| by several factors including calcium release and reuptake, calcium diffusion from the release site to the contractile proteins, and the calcium sensitivity of the contractile proteins. We assume for the purpose of this model that the changes in the a| and i| curves resulting from T3 treatment are due to changes in the r| and h| curves. FIGURE 9. The effect of T3 treatment on the steady-state tension predicted from steadystate activation and inactivation curves (see text) in EDL (A) and soleus (B) fibers. Relative steady-state tension (vertical axis) has been plotted against membrane potential in conditioning K solutions (horizontal axis). Corresponding K concentrations are given along the top of the graphs. The solid lines show steady-state tensions predicted for T3-treated fibers and the broken lines show steady-state tensions predicted for normal fibers (Fig. 6) . The filled symbols show average pedestal tension measured in T3-treated fibers (Table III) and the vertical bars denote + 1 SEM. Note that the scale on the vertical axis is x 0.01 for EDL (A) and x 0.10 for soleus (B).
According to assumptions, a through d, the changes in the voltage dependence of noninactivating tension after T3 treatment follow shifts in the voltage dependence of steady-state activator concentrations as a result of changes in the overlap of the r| and h| curves. The way in which the contraction threshold, measured under voltageclamp conditions with a breif test pulse, is affected by the steady-state values of r and h, and the steady-state activator concentrations at different holding potentials, is summarized in Fig. 10 .
(e) When contraction threshold is examined with a test pulse of duration, T, and variable amplitude, V, the amount of activator formed Ar, v is given by: (7) where subscript "0" designates the steady-state value of the variable before the test pulse, and the subscript "oo" designates the steady-state value that the variable would assume during an infinitely long test pulse. Vh is the holding potential before the test pulse, and ~" is the time constant for activator formation, which depends on the test pulse potential.
AT.V = h0(vh)[r| --(r| --ro)e-r/'(V)]a~
(f) Contraction threshold is reached when a constant amount of activator, Ath, B shows the protocol used to test contraction threshold with a brief depolarization. The solid line shows the test pulse to contraction threshold (Vm) from a negative holding potential (V~f) at which h 0 = 1 and r0 = 0. The dashed line indicates a more positive holding potential, V~, at which h0 ~-1 and r 0 > 0 and the dashed-dotted line, an even more positive holding potential at which h0 < 1 and r0 > 0. C shows activator concentration vs. time after depolarization (first vertical dashed line) during a long depolarization. The second dashed line shows the end of the brief test pulse and marks the relative activator concentration at that time. The holding potential for each response is shown to the right of the curves. The solid line shows the response to the pulse from V~t, the dashed line shows the response to the pulse from V1, and the dashed<lotted line, the response to the pulse from V2. Note that the activator concentration during the long pulse is greatest in the response from V~, less in the response from V], and still smaller in the response from V~. The steady-state activator concentrations at holding potentials V I and V~ are show on the left vertical axis, as well as the threshold concentration, Am. Note (a) that the steady-state activator concentration is greater at I/1 than V~, (b) that the concentration of activator is greater after the brief pulse from Vt than the pulse from Vref so that the test pulse potential must be reduced to more negative potentials to achieve Am, and (c) that the concentration of activator at the termination of the brief test pulse is less after the pulse from Vl than the pulse from V~ so that the test pulse potential must be increased to more positive potentials to achieve A~. has been formed. At, is a fraction, x, of Am~, At, = xAm~ (8) (g) At very negative membrane potentials where r0 ~ 0 and h0 = 1 (e.g., Vr, f in Fig.  10) , A~, is given by:
At"(T,V~) = r| Amax (9) where Vt" is the threshold membrane potential for contraction with a test pulse from the negative holding potential. The following arguments consider the effect of changing holding potential to a more positive value, Vp, on the amount of activator after a test pulse to Vt".
(h) At less negative holding potentials (e.g., V~ in Fig. 10 ), where r0 > 0 and h0 < 1, a test pulse to Vt" releases Ap, given by:
Ap~r,v~) formed by a test pulse from the positive holding potential (Vp) is less than At" (r,v.) at the negative holding potential (Vra) because ho(vp) is less than ho(wo and r~vp) is greater than ro(v.,).
(i) Clearly the total activator concentration, AT, after the test pulse from holding potentials at which r0 > 0 (e.g., V~, Fig. 10 ) will be the sum of Ap(r,v.) and the steadystate activator concentration, Ao~v,), (defined in Eq. 6 above) i.e.:
The test pulse voltage must be increased to more positive potentials to achieve the threshold activator concentration and contraction at holding potentials at which Ao(vp) is less than Aa, -Ap (i.e., AT is less than At"), or decreased to more negative potentials when Ao(vp) is greater than At, -Ap (i.e., AT is greater than At"). Under most conditions Ao(v~) is less than At" -Ap (see curve labled V~ in Fig. 10 C) , and the threshold potential becomes more positive as can be seen between -50 and -20 mV in the curves in Fig. 6 . However, Ao(vp) can become greater than At" -Ap if (a) the pulse is brief compared with the time course of activator formation and (b) the holding potential is such that the reduction in h| is small compared with the increase in r| (e.g., VI in Fig. 10 ). Under these conditions:
Ao(vp) ~-rocvp)Ama.
(12) which is clearly greater than:
At" -Ap ~ ro(vp)e-t/'Am~.
Consequently the contraction threshold would fall to more negative membrane potentials. Such a fall in threshold can be seen between -80 and -50 mV in Fig.  6 . According to the model the effect of T3 treatment on the threshold vs. holding potential curve can be explained by a positive shift in the h| curve in EDL fibers and a negative shift in soleus (shifts predicted by the measured changes in the i| curves), which produces changes in steady-state activator concentrations such that the holding potential at which Ar falls below At" shifted to more positive potentials in EDL, or more negative potentials in soleus.
DISCUSSION
General Considerations
Expression of the inactivation process in excitation-contraction coupling is influenced by thyroid hormone as are many other aspects of muscle contraction (Fitts et al., 1980; Nicol and Bruce, 1981; Nicol and Maybee, 1982; Capo and Sillau, 1983; Dulhunty et al., 1986 Dulhunty et al., , 1987 Caroccia et al., 1988) . A simplistic assumption was made (see Results) that changes in the activation and inactivation curves after T3 treatment arose in a voltage-dependent activator molecule. The assumption is reasonable for inactivation, since the myofilament response does not inactivate (e.g., Stephenson and Williams, 1981) . Changes in tension-activation probably also arise in the activator molecule since parallel changes are seen in asymmetric charge movement (Dulhunty et al., 1987) . The tension-activation curve could be influenced by the calcium sensitivity of the myofilaments; there are conflicting reports about the effect of T3 treatment on the myofilament response (Gold et al., 1970; Fitts et al., 1980; Nicol and Bruce, 1981) . However, a shift in the calcium activation curve to lower calcium concentrations (Caroccia et al., 1988) could contribute to the negative shift in the tension vs. membrane potential curve in EDL fibers, but not to the positive shift in soleus.
The T3 data show that the contractile properties of the fiber can be altered independently from the voltage dependence of activation. The twitch and tetanus in EDL became faster, yet the voltage dependence of the activation and inactivation curves changed towards that of slower fibers. Other procedures that alter contraction speed usually alter the voltage sensitivity of excitation-contraction coupling in the same sense Gage, 1983, 1985) ; for example, spinal cord section produced a faster twitch in soleus and the activation curve became similar to that seen in faster EDL fibers. The rate of activator formation may be altered in the same way as the twitch after T3 treatment since the rate of rise of K contracture tension was faster in EDL and soleus fibers. Although it is unlikely that the myofilament response contributes to twitch contraction times at temperatures above 20"C (Chua and Dulhunty, 1987a, b) , several factors other than the response of the voltage-sensitive activator molecule influence the rate of tension development. The properties of the calcium release channel in the sarcoplasmic reticulum, calcium removal by the calcium ATPase in the sarcoplasmic reticulum, and calcium buffering by parvalbumin (Heizmann et al., 1982) regulate the rate of change of calcium concentration (Chua and Dulhunty, 1987a, b) and could be modified by thyroid hormone.
Predictions of the Irutep~t Model for the Activation and Inactivation of Contraction
There were three apparent discrepancies between the results of K contracture and voltage-clamp experiments, at least some of which could be attributed to changes in the electrical properties of the T system during prolonged depolarization. Such changes in the T tubule properties would influence K contractures more strongly than the threshold measurements because the threshold measurements depend only on depolarization of the T tubule membrane that is very close to the fiber surface. However, the model for activation and inactivation outlined in the Results section adequately explains the three discrepancies, which are: (a) K contracture tension was influenced by inactivation at more negative membrane potentials (-60 mV in EDL, Fig. 5 A) than contraction threshold measured with a 15-ms test pulse (-40 mV in EDL, Figs. 6 and 7) . The model predicts that a fall in maximum contracture tension is not necessarily accompanied by an increase in contraction threshold. Maximum K contracture tension must fall in any holding potential at which h0 < 1. However, at the same holding potential, contraction threshold measured with a brief pulse may be unchanged or fall to more negative membrane potentials if the total activator concentration after the brief test pulse is greater than the total activator concentration after the test pulse from a very negative membrane potential (see assumption f in the Results section).
(b) T3 treatment caused a 15-mV shift to more negative potentials in the threshold membrane potential vs. holding potential curve (Figs. 6 and 7), but only a 4-mV shift in the steady-state inactivation curve in soleus (Fig. 5) . The larger change in threshold measured with brief pulses can be attributed to the negative shift in the h| curve combined with an altered voltage dependence of A| which accounts for the 60% drop in noninactivating tension, Fig. 9 ). The model (assumption f) predicts that the altered voltage dependence of A| alone would shift the threshold vs. holding potential curve to the left.
(c) The threshold membrane potential increased over a narrow range of potentials (Fig. 6) , at about the midpoint (Vi) of the inactivation curves (Fig. 5) . On the lefthand side of the curves the model predicts that threshold would increase at more positive potentials than the fall in contracture tension (point a above). At the righthand side of the curves, full inactivation occurred at more negative potentials when tested with brief pulses than with 200 mM K solutions: at a holding potential of -20 mV normal EDL fibers could not be made to contract with a 15-ms pulse (Figs. 6 and 7) yet, at -20 mV on the tension vs. membrane potential curve (Fig. 5) , tension was greater than zero. A stronger effect of inactivation on contraction elicited with a test pulse is predicted if the test pulse is brief compared with the time course of activator formation. The available activator concentration is reflected in the tension response to a long depolarization (i.e., a 200 mM K contracture). When the available activator concentrations approach Am the fibers will not contract when stimulated with the test pulse, no matter how strong the depolarization, as long as the test pulse is brief compared with the time course of activator formation. Obviously, when the available activator concentration falls below Ath, the fibers will be fully inactivated and will not contract in response to any form of depolarization.
The presence of noninactivating tension did not influence threshold measurements in control EDL or T3-treated soleus fibers since most fibers were inexcitable by the brief test pulse in the range of membrane potentials in which pedestal tensions were recorded. However, normal soleus and T3-treated EDL fibers demonstrated additional contraction when stimulated by brief pulses at membrane potentials where noninactivating tension was recorded. Obviously the true threshold for contraction was exceeded before the test pulse was applied and very little additional activator was required to initiate additional tension. Therefore the measured contraction threshold should have been very close to the holding potential. Threshold and holding potential were in fact parallel over a small range of membrane potentials, around -40 mV in control soleus and TB-treated EDL fibers (Fig. 6) .
It was suggested that the increase in contraction threshold as a result of inactivation occurred at more positive holding potentials than the reduction in K contracture tension because of the contribution of steady-state activator to total activator concentrations. It might be expected that steady-state activator concentrations would rise gradually to the threshold level for contraction, and this was supported by the fact that the predicted effect of steady-state activator on contraction threshold occurred at holding potentials between -70 and -50 mV (Fig. 6) , i.e., potentials that were negative to the potentials at which noninactivating tension was apparent (i.e., -40 to -10 mV, Fig. 9 and Table III) .
Models for Contractile Activation
The use of the activation and inactivation curves to predict "window" or noninactivating tension requires a basic assumption that the activation and inactivation mech- anisms are independent voltage-sensitive processes that control activator formation. Evidence that independent mechanisms exist is derived from the opposite effects of T3 treatment on the voltage sensitivity of the activation and inactivation curves and a pharmacological separation of the two processes (e.g., Caputo and Bolanos, 1986) . A physical concept of the independent model is shown in Fig. 11 . The molecule in the T tubule membrane that controls contraction has two voltage-sensitive subunits, R and H, with the resting orientations shown in Fig. 11 .4. With depolarization, R rapidly changes orientation and allows the molecule to assume the active conformation shown in Fig. 11 B. The H subunit changes orientation more slowly but, with prolonged depolarization, also rotates and induces a further conformational change so that the molecule becomes inactive (Fig. 11 C) . Upon repolarizafion both R and H must resume their original orientations before the molecule can be reactivated. The recovery of the R subunit is fast since recovery from brief depolarization is rapid, but recovery of the H subunit is slow, which explains the slow repriming of muscle fibers after prolonged depolarization (see e.g., Hodgkin and Horowicz, 1960) . The changes in orientation of R and H require the dissociation of calcium ions after depolarization, or binding of calcium ions after repolarization, to explain the effects of low calcium solutions and dihydropyridines on contraction seen in separate experiments (Dulhunty and Gage, 1988) .
Other models for contractile activation assume that the voltage-dependent molecule in the T system undergoes sequential changes from precursor to activated and inactivated states. Dulhunty and Gage (1988) suggested the following scheme:
where the conversion of precursor (P) to Q is voltage sensitive and charge generating.
Step Q to A (activator) requires the dissociation of calcium, while A to I (inactivated state) is voltage sensitive and also requires the removal of calcium. Repriming occurs upon repolarization and calcium binding to I and A. Clearly the sequential model could account for noninactivating tension if the voltage-sensitive rate constants, k(PQ), k(QP), k(AI), and k(IA) are given values that produce a steady-state concentration of A at appropriate membrane potentials. The effects of T3 treatment would then be attributed to changes in the rate constants and the threshold results could be explained in terms of a requirement for constant threshold concentrations of activator for contraction, in the same way as the independent model (see Results).
Conversely, an independent model could account for the results presented by Dulhunty and Gage (1988) if, as in the sequential scheme, both the activation and inactivation steps were calcium dependent. The T3 treatment experiments have enabled us to test an independent model and the results provide support for that model, but do not exclude a sequential scheme.
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